Is It Time to Reconsider the Lipopolysaccharide Paradigm in Acute Graft-Versus-Host Disease?

Daguindau, Etienne; Gautier, Thomas; Chagué, Cécile; Pais de Barros, Jean-Paul; Deckert, Valérie; Lagrost, Laurent; Saas, Philippe

Daguindau, Etienne; Gautier, Thomas; Chagué, Cécile; Pais de Barros, Jean-Paul; Deckert, Valérie; Lagrost, Laurent; Saas, Philippe.

Afiliación

Daguindau E; Université Bourgogne Franche-Comté, EFS Bourgogne Franche-Comté, INSERM, UMR1098, Besançon, France.
Gautier T; Department of Hematology, University Hospital of Besançon, Besançon, France.
Chagué C; LipSTIC LabEx, FHU INCREASE, Besançon, France.
Pais de Barros JP; INSERM, Université Bourgogne Franche-Comté, LNC UMR1231, Dijon, France.
Deckert V; LipSTIC LabEx, Dijon, France.
Lagrost L; Université Bourgogne Franche-Comté, EFS Bourgogne Franche-Comté, INSERM, UMR1098, Besançon, France.
Saas P; Department of Hematology, University Hospital of Besançon, Besançon, France.

Front Immunol ; 8: 952, 2017.

Article en En | MEDLINE | ID: mdl-28848554

Palabras clave

Escherichia coli; PLTP; TLR4; endotoxin; graft-versus-host disease; lipopolysaccharide; lipoproteins; microbiota

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Idioma: En Revista: Front Immunol Año: 2017 Tipo del documento: Article País de afiliación: Francia